Abstract
Discovery of new therapeutics is a very challenging, expensive and time-consuming process. With the number of approved drugs declining steadily, combined with increasing costs, a rational approach is needed to facilitate, expedite and streamline the drug discovery process. In silico methods are playing key roles in the discovery of a growing number of marketed drugs. The use of computational approaches, particularly molecular dynamics, in drug design is rapidly gaining momentum and acceptance as an essential part of the toolkit for modern drug discovery. From analysing atomistic details for explaining experimentally observed phenomena, to designing drugs with increased efficacy and specificity, the insight that such simulations can provide is generating new ideas and applications that have previously been unexplored. Here we discuss physics-based simulation methodologies and applications in drug design: from locating pockets to designing novel lead compounds, from small molecules to peptides. With developments in hardware, software and theory, the improved predictive abilities of in silico efforts are becoming an essential part of efficient, economic and accurate drug development strategies.
Keywords: Molecular dynamics, coarse grain, solvent mapping, staple peptides, antimicrobial peptides.
Current Pharmaceutical Design
Title:The Multifaceted Roles of Molecular Dynamics Simulations in Drug Discovery
Volume: 22 Issue: 23
Author(s): Stephen John Fox, Jianguo Li, Yaw Sing Tan, Minh N. Nguyen, Arumay Pal, Zohra Ouaray, Shilpa Yadahalli and Srinivasaraghavan Kannan
Affiliation:
Keywords: Molecular dynamics, coarse grain, solvent mapping, staple peptides, antimicrobial peptides.
Abstract: Discovery of new therapeutics is a very challenging, expensive and time-consuming process. With the number of approved drugs declining steadily, combined with increasing costs, a rational approach is needed to facilitate, expedite and streamline the drug discovery process. In silico methods are playing key roles in the discovery of a growing number of marketed drugs. The use of computational approaches, particularly molecular dynamics, in drug design is rapidly gaining momentum and acceptance as an essential part of the toolkit for modern drug discovery. From analysing atomistic details for explaining experimentally observed phenomena, to designing drugs with increased efficacy and specificity, the insight that such simulations can provide is generating new ideas and applications that have previously been unexplored. Here we discuss physics-based simulation methodologies and applications in drug design: from locating pockets to designing novel lead compounds, from small molecules to peptides. With developments in hardware, software and theory, the improved predictive abilities of in silico efforts are becoming an essential part of efficient, economic and accurate drug development strategies.
Export Options
About this article
Cite this article as:
John Fox Stephen, Li Jianguo, Sing Tan Yaw, N. Nguyen Minh, Pal Arumay, Ouaray Zohra, Yadahalli Shilpa and Kannan Srinivasaraghavan, The Multifaceted Roles of Molecular Dynamics Simulations in Drug Discovery, Current Pharmaceutical Design 2016; 22 (23) . https://dx.doi.org/10.2174/1381612822666160425120507
DOI https://dx.doi.org/10.2174/1381612822666160425120507 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Inflammatory Iridoids of Botanical Origin
Current Medicinal Chemistry Electrochemical and Electrochemiluminescence Dendrimer-based Nanostructured Immunosensors for Tumor Marker Detection: A Review
Current Medicinal Chemistry New Approaches to Mechanism Analysis for Drug Discovery Using DNA Microarray Data Combined with KeyMolnet
Current Drug Discovery Technologies Targeted Cancer Therapeutics: Biosynthetic and Energetic Pathways Characterized by Metabolomics and the Interplay with Key Cancer Regulatory Factors
Current Pharmaceutical Design Lycopene Modulation of Molecular Targets Affected by Smoking Exposure
Current Cancer Drug Targets HPV Cervical Infection and Immunodysregulation: Synergistic Risks for Neoplasia-Review
Current Women`s Health Reviews Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Bioactive Flavonoids from Cornus mas L. Fruits
Mini-Reviews in Organic Chemistry Can PET Imaging Facilitate Optimization of Cancer Therapies?
Current Pharmaceutical Design Araucaria Angustifolia: A Potential Nutraceutical with Antioxidant and Antimutagenic Activities
Current Nutrition & Food Science Molecular Determinants of Chronic Liver Disease as Studied by NMR-Metabolomics
Current Topics in Medicinal Chemistry Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Current Pharmaceutical Design Dendrimers - Nanoparticles with Precisely Engineered Surfaces
Current Organic Chemistry Characterization Of A Hemagglutinating Glycoprotein Isolated From Bothrops Moojeni Snake Venom
Protein & Peptide Letters Recent Advances in Physical Approaches for Transdermal Penetration Enhancement
Current Drug Therapy The Past, Current Studies and Future of Organometallic <sup>99m</sup>Tc(CO)3 Labeled Peptides and Proteins
Current Pharmaceutical Design Implantable Microfluidic Device: An Epoch of Technology
Current Pharmaceutical Design Antimutagenic Activity of Lutein –An Oxycarotenoid Present in the Macula and its Inhibition of Cytochrome P 450 Enzymes in vitro
Drug Metabolism Letters Computational Models for Predicting Interactions with Cytochrome p450 Enzyme
Current Topics in Medicinal Chemistry Fluorescence Detection of MMP-9. I. MMP-9 Selectively Cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys Peptide
Current Pharmaceutical Biotechnology